The all-cash settlement will be placed in an escrow account that the Plaintiffs recommended be administered by Citibank NA. Read more
More than 1,200 Mirena cases have been filed in the federal court Multidistrict Litigation (MDL) and are now pending. Read more
The FDA has said that despite the more than 5,000 complaints on Essure it has received since its approval, it is still a compelling option since it is the only sterilization procedure for pa... Read more
It should be noted that beekeepers and honey producers aren’t the only ones who suffer from the collapse of bee colonies. Read more
Lawyers in our firm’s Mass Torts Section are pleased to report that after years of litigation involving Bayer’s drosperinone-containing oral contraceptives, including Yaz, Yasmin, Ocella, Gi... Read more
A federal judge in New Jersey has refused to reconsider his order allowing two False Claims Act (FCA) claims in a whistleblower’s long-running suit against Bayer Corp. for allegedly pu... Read more
In an effort to shore up its conflict-of-interest policies, the Food and Drug Administration has finalized policies for publicly disclosing the financial ties of advisory board members whose... Read more
A U.S. Food and Drug Administration (FDA) panel has voted that there is not enough scientific proof to support claims that naproxen, a painkiller sold as Aleve by Bayer Corp., is safer than... Read more
Bayer has agreed to a $74 million settlement in a case where Plaintiffs alleged the drug maker violated antitrust laws by participating in pay-for-delay activities surrounding its drug Cipro... Read more
Bayer could pay more than $1.2 billion to settle personal injury lawsuits over the company’s Yaz and Yasmin birth control pills, according to a recent stock filing. As part of its second qua... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.